Presentation Analysis

Overview

Case Summary

• Facial rash aggravated by sun exposure (photosensitivity)
• Difficulty combing hair, climbing stairs, and rising from a squatting position (proximal muscle weakness)

Examination Findings

• Multiple discrete to grouped hyperpigmented papules and papulonodules with central ulceration and crusting, healing with varioliform scars
• Generalized distribution - predominantly trunk and upper extremities
• Heliotrope rash over both upper eyelids
• Facial erythema over the malar area
• Gottron papules over the MCP and PIP joints
• Gottron sign over the extensor surfaces
• Erythematous scaly plaques with crusting over the scalp

• Proximal muscle weakness - shoulder and pelvic girdle muscles (distal power preserved)
• Respiratory, cardiovascular, abdominal: normal

Differentials Considered (Slide 9-10)

1. Reactive Perforating Collagenosis (RPC)
2. Perforating Folliculitis
3. Elastosis Perforans Serpiginosa (EPS)
4. Kyrle Disease
5. Degos Disease (Malignant Atrophic Papulosis)

Investigations

Histopathology Findings

• Cup-shaped epidermal invagination containing basophilic degenerated collagen bundles, inflammatory cells, and keratinous debris
• Transepidermal elimination of degenerated collagen bundles
• Underlying dermis with mixed inflammatory infiltrate and vertically oriented collagen bundles extending toward the epidermis

Final Diagnosis

Discussion Highlights

• RPC is a rare perforating dermatosis characterized by transepidermal elimination of altered collagen
• Usually inherited or acquired; the acquired form is classically linked to DM and CKD - but this case demonstrates an uncommon association with autoimmune connective tissue disease (dermatomyositis)
• Proposed pathogenesis: microvascular injury + altered collagen metabolism + repetitive trauma (Koebner phenomenon) → transepidermal collagen elimination

Learning Points

1. Rare association: RPC + dermatomyositis is uncommon; always consider underlying autoimmune disease in generalized perforating dermatoses
2. Diagnostic clues: Heliotrope rash, Gottron papules, photosensitivity, and proximal muscle weakness should prompt myopathy workup
3. Clinicopathological correlation supported by myositis-specific antibody profile (anti-OJ, Ro-52, PM-Scl75) was key to establishing the diagnosis
4. Anti-OJ positivity is notable - this is an anti-synthetase antibody associated with the antisynthetase syndrome, which can manifest with ILD (consistent with the GGO on HRCT), myositis, and cutaneous features
5. Early recognition and multidisciplinary management are essential

Strengths of the Presentation

• Well-structured case with a clear clinical narrative
• Differentials appropriately narrowed to perforating dermatoses
• Excellent use of specific dermatomyositis signs (heliotrope, Gottron papules/sign)
• Investigations logically guided - CPK/LDH for muscle involvement, myositis antibody panel for subtyping
• The discovery of anti-OJ adds nuance - this is an antisynthetase syndrome variant, which is clinically significant due to ILD risk
• Histopathology findings precisely described and match RPC criteria

Suggestions / Points to Highlight in Discussion

• The anti-OJ antibody (anti-isoleucyl-tRNA synthetase) is one of the rarer antisynthetase antibodies (anti-Jo-1 being the most common); its presence here with ILD on HRCT fits the antisynthetase syndrome spectrum
• The PM-Scl75 positivity hints at a possible overlap syndrome (PM-Scl is associated with myositis-scleroderma overlap)
• Treatment would typically involve systemic corticosteroids + steroid-sparing agents (methotrexate, azathioprine) and ILD monitoring
• The HRCT finding warrants pulmonology co-management

Dermatomyositis-Specific Antibodies

• Myositis-Specific Antibodies (MSAs) - found almost exclusively in inflammatory myopathies; define clinical subtypes
• Myositis-Associated Antibodies (MAAs) - seen in myositis overlapping with other CTDs

I. Myositis-Specific Antibodies (MSAs) in Dermatomyositis

1. Anti-Mi-2

• Target: Nucleosome remodeling-deacetylase (NuRD) complex (transcription regulation)
• Frequency: Up to 31% of DM cases
• Clinical associations:
  • Classic "V-sign," shawl sign, cuticular overgrowth
  • Relatively mild muscle disease
  • Typical cutaneous DM lesions (heliotrope, Gottron papules)
  • Good prognosis and treatment response
  • Low risk of malignancy and ILD

2. Anti-MDA5 (anti-CADM-140)

• Target: RNA helicase encoded by melanoma differentiation-associated gene 5 (innate antiviral defense)
• Clinical associations:
  • Clinically amyopathic DM (CADM) - prominent skin disease, minimal/no myositis
  • Rapidly progressive, therapy-resistant ILD - potentially fatal
  • Oral and skin ulceration, fever
  • Inflammatory arthritis/arthralgia
  • Palmar papules ("inverse Gottron")
  • Originally described in East Asian populations; now recognized globally
• Prognosis: Worst of all MSAs if ILD develops; requires urgent aggressive treatment

3. Anti-TIF1-γ (anti-p155/140)

• Target: Transcriptional intermediary factor 1-gamma (nuclear transcription factor overexpressed in solid tumors)
• Frequency: Up to 35% of JDM cohorts
• Clinical associations:
  • Aggressive skin disease - photosensitivity, malar rash, Gottron papules, V-sign, cuticular overgrowth
  • Strong association with malignancy in adults >40 years (up to 75% of anti-TIF1-γ positive adults have an underlying cancer)
  • Adenocarcinomas: cervix, lung, ovary, pancreas, bladder, stomach
  • In juveniles (JDM): chronic/polycyclic disease course, cutaneous ulceration - cancer association is extremely uncommon
• Key point: Anti-TIF1-γ positivity in an adult = mandatory cancer screen

4. Anti-NXP-2 (anti-MJ)

• Target: Nuclear matrix protein 2 (NXP-2) - roles in RNA metabolism, nuclear architecture, p53 regulation
• Clinical associations:
  • Severe cutaneous disease
  • Calcinosis - markedly increased odds (OR 7.0); most strongly calcinosis-associated antibody
  • Muscle cramping and weakness requiring hospitalization
  • Dysphonia
  • Younger age at onset in juveniles; less frequent remission
  • Possible malignancy association in adults (less established than anti-TIF1-γ)

5. Anti-SAE (Small Ubiquitin-like Modifier Activating Enzyme)

• Target: SAE1/SAE2 - involved in protein SUMOylation (post-translational modification)
• Clinical associations:
  • Associated with DM
  • Often presents with dysphagia early
  • May progress from amyopathic to classic DM
  • Characteristic features still being defined; less well-studied than other MSAs
  • Reported more in European cohorts

II. Anti-Synthetase Antibodies (MSAs - Antisynthetase Syndrome)

• Inflammatory myopathy
• Mechanic's hands (hyperkeratotic fissured skin on fingers)
• ILD (can be the sole feature)
• Inflammatory arthritis
• Raynaud's phenomenon
• Fever
• Lipoatrophy

III. Myositis-Associated Antibodies (MAAs) - Overlap Significance

In the presented case: Anti-OJ + Ro-52 + PM-Scl75 - this combination points to an antisynthetase syndrome with overlap features and high ILD risk. The HRCT finding of ground-glass opacity in the right lower lung confirms subclinical ILD.

Quick Reference Summary Table